Manufacturer record
Mayasha Lifesciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Mayasha Lifesciences (Himachal Pradesh) were declared Not of Standard Quality between April 2025 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Mayasha Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | MDT-4458Mfg 2025-09 · Exp 2027-08 | The sample does not conform to the claim with respect to Assay of Aceclofenac.Assay | DTL JaipurState lab | Jan 2026 |
| Deflazacort Tablets (Shedef) | MDT-3876Mfg 2025-03 · Exp 2027-02 | Assay of Deflazacort. 3.45mg (57.5%) found as claimed 6 mg)Assay | DTL Baddi H.PState lab | Oct 2025 |
| Acclofenac, Paracetamol & Serratiopeptidase Tablets(ASPAZ) | MDT-4102Mfg 2025-05 · Exp 2027-04 | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab | Oct 2025 |
| Sulphamethoxazole and Trimethoprim Tablets IP | MT386Mfg 2023-10 · Exp 2026-09 | Dissolution of Sulphamethoxazol eDissolution | RDTL ChandigarhCDSCO lab | Apr 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.